BCPEM
TTPH

Bain Capital Public Equity Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bain Capital Public Equity Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-18,376
Closed -$2.58M – 58
2013
Q2 		$2.58M Buy
+18,376
New +$2.91M 0.06% 43

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Bain Capital Public Equity Management's TTPH Position: Q3 2013 in Review

Bain Capital Public Equity Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2013, closing a stake of 18,376 shares — an estimated $2.58M sold.

Bain Capital Public Equity Management first reported a position in TTPH in Q2 2013 and held it in 1 quarter. The position peaked at $2.58M in Q2 2013. 39 funds tracked by Wall St. Rank hold TTPH as of Q3 2013.

  • Bain Capital Public Equity Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2013 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 18,376 Tetraphase Pharmaceuticals, Inc. shares in Q3 2013, an estimated $2.58M.
  • Bain Capital Public Equity Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 1 quarter.
  • Bain Capital Public Equity Management's Tetraphase Pharmaceuticals, Inc. position peaked at $2.58M in Q2 2013.
  • 39 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2013.

Based on Bain Capital Public Equity Management's 13F filing for Q3 2013, filed 12 Nov 2013.